Dr. Vikram Karnik talks with Dr. Lorraine V. Kalia about the potential role of GLP-1 receptor agonists in neurodegenerative diseases, the current state of research, preclinical evidence, and future directions for GLP-1 agonists. Read the related…
Read MoreDr. Jeff Ratliff talks with Dr. Maureen Leehey about the short-term efficacy and tolerability of high-CBD/low-THC cannabis extract on the motor symptoms in patients with Parkinson disease. Read the related article in the . This podcast is…
Read MoreDr. Vikram Karnik talks with Dr. Rob de Bie about early vs. delayed start of Levodopa in early Parkinson disease, and what it means for clinical practice. Read the related article in . This podcast is sponsored by argenx. Visit for more information….
Read MoreDr. Jason Crowell talks with Dr. Subhojit Roy about a platform for investigating the role of serine-129 in synucleinopathies, with implications for drug development. Read the related article in the . Disclosures can be found at .
Read MoreDr. Jeff Ratliff talks with Dr. Jason Margolesky about the frequency of blepharoclonus in Parkinson disease and atypical Parkinsonian disorders to explore whether this clinical phenomenology may be useful in the evaluation and diagnosis of patients…
Read MoreDr. Jeff Ratliff talks with Prof. Andrew Siderowf about the assessment of heterogeneity among participants in the Parkinson progression markers initiative cohort using α-synuclein seed amplification. Read the related article in . Disclosures can be…
Read MoreDr. Jeff Ratliff talks with Dr. Rob de Bie about the effects of levodopa in patients with early Parkinson disease. Read the related article in . This podcast is sponsored by argenx. Visit for more information. Disclosures can be found at .
Read More
Comentarios recientes